vancomycin has been researched along with organophosphonates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashley, JA; Isomura, S; Janda, KD; Wirsching, P | 1 |
| Abskharon, R; Berger, G; Canaan, S; Cavalier, JF; Evrard, D; Fontaine, V; Khan, MS; Prévost, M; Soumillion, P; Vandenbussche, G; Vertommen, D; Wohlkönig, A; Yang, D; Zeng, S | 1 |
2 other study(ies) available for vancomycin and organophosphonates
| Article | Year |
|---|---|
Antibody-catalyzed cleavage of the D-Ala-D-Lac depsipeptide: an immunological approach to the problem of vancomycin resistance.
Topics: Animals; Antibodies, Monoclonal; Catalysis; Dipeptides; Drug Resistance; Haptens; Hydrolysis; Kinetics; Mice; Organophosphonates; Vancomycin | 2002 |
Methyl arachidonyl fluorophosphonate inhibits Mycobacterium tuberculosis thioesterase TesA and globally affects vancomycin susceptibility.
Topics: Anti-Bacterial Agents; Arachidonic Acids; Bacterial Proteins; Catalytic Domain; Drug Resistance, Bacterial; Enzyme Inhibitors; Molecular Docking Simulation; Mycobacterium tuberculosis; Organophosphonates; Protein Binding; Protein Multimerization; Thiolester Hydrolases; Vancomycin | 2020 |